Insider · CIK 0001167496
Clay B Siegall
ceopresidentofficerdirector
Files at IMNM (Immunome Inc.). First filing Nov 25, 2024, latest Mar 26, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
3 / 0
$3.1M bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMNM: Immunome Inc.
IMNMOct 9, 2026 · close 19.55
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 76Notable | Immunome Inc. | $999k 137,100 shares | +20% | - | |
| 61Notable | IMNMbuy Immunome Inc. | $1.2M 150,000 shares | +29% | - | |
| 70Notable | Immunome Inc. | $962k 100,000 shares | +24% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | IMNM Immunome Inc. | POpen-market purchase Common Stock | +137,100 | $7.29 | $999k | 806,736 | Mar 26, 2025 |
| Jan 31, 2025 | IMNM Immunome Inc. | POpen-market purchase Common Stock | +150,000 | $7.75 | $1.2M | 669,636 | Feb 3, 2025 |
| Nov 21, 2024 | IMNM Immunome Inc. | POpen-market purchase Common Stock | +66,057 | $9.54 | $630k | 485,693 | Nov 25, 2024 |
| Nov 22, 2024 | IMNM Immunome Inc. | POpen-market purchase Common Stock | +33,943 | $9.78 | $332k | 519,636 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.